Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genesis Healthcare
Providers
E&C subcommittee weighs suggestions to fix 340B drug program
Policy researchers and providers encouraged lawmakers Tuesday to embrace transparency and statutory clarifications for the drug discount program.
Dave Muoio
Jun 4, 2024 5:30pm
Healthcare Dealmakers—CVS closes $8B Signify purchase and more
Apr 4, 2023 4:35pm
Healthcare Dealmakers—CVS drops $8B into home health and more
Oct 6, 2022 4:48pm
Premier, 11 systems buy minority stake in specialty drug maker
Sep 9, 2021 11:00am
Hospital groups urge CMS to withdraw plan to cut 340B payments
Sep 12, 2017 10:44am
Genesis will pay $53.6M to settle slew of allegations
Jun 19, 2017 12:17pm
